Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Fugger

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Nature Immunology|February 26, 2024
A repair pathway lost in multiple sclerosis provides a new drug opportunityLise Torp Jensen, Kathrine E Attfield, Lars Fugger
Trends in Immunology|September 6, 2005
MHC II molecules in inflammatory diseases: interplay of qualities and quantitiesManuel A Friese, E Yvonne Jones, Lars Fugger
Trends in Molecular Medicine|April 16, 2013
Therapies for multiple sclerosis: translational achievements and outstanding needsAiden Haghikia, Reinhard Hohlfeld, Ralf Gold, et al.
Nature Medicine|February 8, 2013
Weighing in on autoimmune disease: Big data tip the scaleCalliope A Dendrou, John I Bell, Lars Fugger
Nature Reviews. Immunology|May 16, 2009
From genes to function: the next challenge to understanding multiple sclerosisLars Fugger, Manuel A Friese, John I Bell
Nature Reviews. Immunology|January 3, 2018
HLA variation and diseaseCalliope A Dendrou, Jan Petersen, Jamie Rossjohn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptorIoana Moisini, Phuong Nguyen, Lars Fugger, et al.
Journal of Autoimmunity|June 3, 2008
Dissection of the multiple sclerosis associated DR2 haplotypeRuth Etzensperger, Róisín M McMahon, E Yvonne Jones, et al.
Nature Medicine|January 10, 2012
Autoimmunity's next top modelsHartmut Wekerle, Alexander Flügel, Lars Fugger, et al.
Nature Reviews. Immunology|March 25, 2006
MHC class II proteins and disease: a structural perspectiveE Yvonne Jones, Lars Fugger, Jack L Strominger, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Nature Immunology|February 26, 2024
A repair pathway lost in multiple sclerosis provides a new drug opportunityLise Torp Jensen, Kathrine E Attfield, Lars Fugger
Trends in Immunology|September 6, 2005
MHC II molecules in inflammatory diseases: interplay of qualities and quantitiesManuel A Friese, E Yvonne Jones, Lars Fugger
Trends in Molecular Medicine|April 16, 2013
Therapies for multiple sclerosis: translational achievements and outstanding needsAiden Haghikia, Reinhard Hohlfeld, Ralf Gold, et al.
Nature Medicine|February 8, 2013
Weighing in on autoimmune disease: Big data tip the scaleCalliope A Dendrou, John I Bell, Lars Fugger
Nature Reviews. Immunology|May 16, 2009
From genes to function: the next challenge to understanding multiple sclerosisLars Fugger, Manuel A Friese, John I Bell
Nature Reviews. Immunology|January 3, 2018
HLA variation and diseaseCalliope A Dendrou, Jan Petersen, Jamie Rossjohn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptorIoana Moisini, Phuong Nguyen, Lars Fugger, et al.
Journal of Autoimmunity|June 3, 2008
Dissection of the multiple sclerosis associated DR2 haplotypeRuth Etzensperger, Róisín M McMahon, E Yvonne Jones, et al.
Nature Medicine|January 10, 2012
Autoimmunity's next top modelsHartmut Wekerle, Alexander Flügel, Lars Fugger, et al.
Nature Reviews. Immunology|March 25, 2006
MHC class II proteins and disease: a structural perspectiveE Yvonne Jones, Lars Fugger, Jack L Strominger, et al.
Pageof 12